US Patent 8987333 Composition and method for treating neurological disease
Patent 8987333 was granted and assigned to Adamas Pharmaceuticals, Inc. on March, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+263 characters)
Article
Patent abstract
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the excipients modifies release of amantadine. Methods of administering the same are also provided.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08987333 Composition and method for treating neurological disease US Patent 8987333 Composition and method for treating neurological disease
Infobox
Patent Number
0898733300
Patent Number
898733300
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
089873330
Date of Patent
March 24, 2015
0Patent Application Number
144512620
Date Filed
August 4, 2014
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
089873330
Date of Patent
March 24, 2015
0Patent Application Number
144512620
Date Filed
August 4, 2014
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08987333 Composition and method for treating neurological disease
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08987333
Date of patent
March 24, 2015
Patent application number
14451262
Date Filed
August 4, 2014
Patent primary examiner
Find more entities like US Patent 8987333 Composition and method for treating neurological disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
